Strive Pharmacy

Strive Pharmacy overview

Clinics that rely on one compounding pharmacy lose orders to backorders, slow shipping and rejected scripts, so AffinityRx, a multi-pharmacy marketplace, lets a clinic order from Strive Pharmacy alongside 15+ other vetted pharmacies through one portal, with the order rerouted to the next favorite pharmacy within 1–2 minutes if Strive Pharmacy is out of stock or rejects it. Strive Pharmacy is a 503A compounding pharmacy in Gilbert, AZ on AffinityRx. Clinics can order 2 compounded medications from Strive Pharmacy through AffinityRx, including Glutathione and NAD+, with clinic prices starting at $45.00. Strive Pharmacy states it holds PCAB, NABP, and LegitScript accreditation; AffinityRx has not yet verified this.

Strive Pharmacy is a multi-location compounding pharmacy group headquartered in Gilbert, Arizona, with pharmacies in Arizona, Texas, California, Virginia, Missouri and Florida. It states it is a 503A pharmacy serving providers, clinics and telehealth platforms with sterile and non-sterile compounded medications (weight management, hormones, peptides, hair, skin, sexual wellness and more). It has an FDA warning letter history (closed out in 2026) and recent Texas board discipline and pending Arizona and Florida board matters, detailed below.

Strive Pharmacy compounded medication prices on AffinityRx (October 2026)

AffinityRx lists 2 compounded medications from Strive Pharmacy, with clinic prices from $45.00. Prices are AffinityRx clinic prices, shown before ordering; shipping billed separately.

Single Peptides 2

Strive Pharmacy compliance scorecard

A due-diligence checklist for Strive Pharmacy modeled on the AffinityRx pharmacy review: licensure, accreditation, quality and testing, and regulatory history. Verified items link to a public source. Claimed items are pharmacy statements AffinityRx has not yet verified. Items that are not public are available to AffinityRx clinics on request.

How AffinityRx vets Strive Pharmacy

AffinityRx vets every compounding pharmacy for clinics, and only 9% of the pharmacies AffinityRx reviews pass. Strive Pharmacy is one of the pharmacies that passed.

AffinityRx reviews each pharmacy in five areas:

• Compliance: state licensures, USP <795>, <797> and <800>, and certifications such as LegitScript, PCAB, ACHC and NABP.
• Product: third-party certificates of analysis (COAs), sterility and endotoxin testing, and beyond-use dates.
• Track record: Form 483s, recalls, FDA actions and the pharmacist-in-charge background.
• Market feedback: clinic and patient ratings and reviews, and Reddit threads.
• Operations: shipping times, stock and cold-chain validation.

Public credentials such as license numbers and accreditation proof are published on this profile, and backing documents such as COAs are available to clinics on request.

Warning letters and recalls

If Strive Pharmacy receives an FDA warning letter or recall, AffinityRx notifies clinics and updates this profile. Clinics can switch Strive Pharmacy off in their AffinityRx portal at any time.

Favorites and failover

Clinics pick a pharmacy at checkout, or pre-set a primary pharmacy plus second and third favorites. If the primary pharmacy is out of stock or rejects an order, AffinityRx reroutes it to the next favorite within 1–2 minutes. Prescriber re-sign is the default; turning on auto re-sign removes that step. Read how this works on the backorders page, and see how AffinityRx compares with other compounding pharmacy marketplaces.

Strive Pharmacy licenses and identifiers

Strive Pharmacy's license and registry identifiers, as recorded in public records. Verify any license directly with the issuing board before relying on it.

Non-resident licenses 2

Strive Pharmacy holds non-resident pharmacy licenses in 2 states outside AZ: TX, FL. Statuses are as recorded on the date of the board lookup.

• TX
• FL

Strive Pharmacy regulatory history

AffinityRx found 16 dated regulatory events on public record for Strive Pharmacy. Each entry is factual, dated and linked to its source.

1. Aug 4, 2026State Board ActionTexas State Board of PharmacyStatus: Active - license on probation (TSBP shows license status 'Probation'); 2-year probation began ~30 days after 2026-08-04

   Agreed Board Order #2025-01349 against Strive Pharmacy Texas LLC (San Antonio, license 34585; previously Strive Pharmacy / Talon Pharmacy of Boerne): 321 counts, including 320 dispensings (Apr 2023 - Oct 2024; semaglutide, tirzepatide, peptides, hormone, topical and other compounds) under prescriptions attributed to one physician who allegedly did not authorize them and without a valid patient-practitioner relationship, plus failure to operate the pharmacy legally. Order: 2-year probation, $15,000 administrative penalty, $1,200 probation fee, written prescription-validity policies due in 120 days. Respondent neither admitted nor denied.

   Primary record
2. May 13, 2026OtherFDAStatus: Closed out

   FDA issued a close-out letter on 2026-05-13 for Warning Letter 639220 (issued 2022-08-29 to Vita Pharmacy LLC dba Talon Pharmacy of Boerne; FDA's close-out page is titled Strive Pharmacy Texas LLC). FDA lists it under Vita Pharmacy dba Talon Compounding Pharmacy, San Antonio, TX.

   Primary record
3. Feb 3, 2026State Board ActionTexas State Board of PharmacyStatus: Resolved - reprimand

   Agreed Board Order #2025-02040 reprimanding Strive Pharmacy LLC's Texas non-resident pharmacy license (35643) based on conduct in the Arizona 2024 consent agreement; respondent neither admitted nor denied. Signed on behalf of the pharmacy by its CEO.

   Primary record
4. Sep 4, 2025OtherArizona State Board of Pharmacy (reported by Sherwood News, 2026-02-13; not primary documents)Status: Reported as open as of 2026-02-13; current status unknown

   Press report of AZ board documents: a 2025-09-04 inspection of the Gilbert facility reportedly found continued compounding of single-ingredient semaglutide/tirzepatide after the shortage ended, with templated clinical rationales and 'large amounts of odd strengths/doses in anticipation of prescriptions'; Strive disputes the characterization and asked the board to amend the report. Separately, the AZ board's Complaint Review Committee advanced two complaints on 2025-12-02 (ketamine patches compounded/tested on an employee; prescription drugs supplied to a clinic reportedly selling them over the counter), which the board had not resolved as of the article.

   Primary record
5. Apr 1, 2025OtherFederal court (litigation, not regulatory)Status: Pending/unknown

   Eli Lilly sued Strive Pharmacy LLC (D. Del.) alleging false/deceptive marketing of compounded tirzepatide; web reports say the Delaware case was dismissed for lack of personal jurisdiction and refiled in Arizona (Oct 2025). Strive sued Lilly and Novo Nordisk in January 2026 alleging antitrust violations. Court dockets not independently reviewed.

   Primary record
6. Feb 7, 2024State Board ActionArizona State Board of PharmacyStatus: Resolved by consent agreement ($1,000 civil penalty)

   Consent Agreement and Order for Civil Penalty against Strive Pharmacy LLC (AZ permit Y007406): records for sterile compounded preparations were not adequately maintained (semaglutide acetate recorded where semaglutide sodium was purchased, 66 preparations dispensed from two lots in March-April 2022). $1,000 penalty. Strive states the board did not discipline it for improperly compounding a commercially available product. Described in the TSBP order and Sherwood News;

   Primary record
7. Sep 8, 2023Form 483FDA (Dallas district)Status: Issued; pharmacy response not reviewed

   Inspection of Strive Pharmacy Texas LLC dba Strive Pharmacy, Boerne TX (503A, sterile and non-sterile) on 2023-08-14 to 2023-09-08 produced four observations: facility design allowing lower-quality air into the ISO 7 cleanroom, aseptic technique with exposed hair/skin in the ISO 5 hood (semaglutide/B12 injection), inadequate cleaning/disinfection of equipment in the ISO 5 area, and inadequate cleaning of glassware/utensils.

   Primary record
8. Aug 29, 2022Warning LetterFDA (Office of Pharmaceutical Quality Operations, Division II)Status: Closed out - FDA close-out letter dated 2026-05-13 states corrective actions adequately addressed the violations

   FDA warning letter #639220 addressed to the 503A compounding pharmacy later operated as Strive Pharmacy Texas LLC (then Vita Pharmacy, LLC dba Talon Pharmacy of Boerne, Boerne TX). Text of the original letter not reviewed; FDA's close-out letter confirms the letter and its date.

   Primary record
9. May 20, 2022OtherFDAStatus: Listed

   FDA's compounding actions page lists an FMD-145 letter issued to Vita Pharmacy, LLC, (dba Talon Compounding Pharmacy), San Antonio, TX on 2022-05-20. The letter itself is not linked on the page.

   Primary record
10. Nov 17, 2021RecallFDAStatus: Terminated

    Vita Pharmacy, LLC dba Talon Compounding Pharmacy initiated a recall (recall initiation 2021-10-12; reported in the FDA Enforcement Report 2021-11-17) covering 130 product listing(s). FDA's stated reason: Lack of assurance of sterility. Classification: Class II; status: Terminated.

    Primary record
11. Nov 2, 2021Form 483FDAStatus: Issued (inspectional observations)

    FDA issued a Form FDA 483 to Vita Pharmacy, LLC, (dba Talon Pharmacy of Boerne), Boerne, TX (503A facility) on 2021-11-02. The form lists inspectional observations; topics could not be reliably extracted from the scanned PDF. Form FDA 483 observations are inspectional and do not represent a final FDA determination of compliance.

    Primary record
12. Oct 6, 2021Form 483FDAStatus: Issued (inspectional observations)

    FDA issued a Form FDA 483 to Vita Pharmacy, LLC, (dba Talon Compounding Pharmacy), San Antonio, TX (503A facility) on 2021-10-06. The form lists 3 observation(s), including: cleaning/disinfection. Form FDA 483 observations are inspectional and do not represent a final FDA determination of compliance.

    Primary record
13. Jul 8, 2020OtherFDAStatus: Listed

    FDA's compounding actions page lists an FMD-145 letter issued to Vita Pharmacy, LLC, (dba Talon Pharmacy of Boerne), Boerne, TX on 2020-07-08. The letter itself is not linked on the page.

    Primary record
14. Feb 11, 2020Form 483FDAStatus: Issued (inspectional observations)

    FDA issued a Form FDA 483 to Vita Pharmacy, LLC, (dba Talon Pharmacy of Boerne), Boerne, TX (503A facility) on 2020-02-11. The form lists inspectional observations; topics could not be reliably extracted from the scanned PDF. Form FDA 483 observations are inspectional and do not represent a final FDA determination of compliance.

    Primary record
15. Aug 31, 2016RecallFDAStatus: Terminated

    Talon Compounding Pharmacy initiated a recall (recall initiation 2016-07-19; reported in the FDA Enforcement Report 2016-08-31) covering 2 product listing(s). FDA's stated reason: Lack of Assurance of Sterility. Classification: Class II; status: Terminated.

    Primary record
16. NoneState Board ActionFlorida Department of Health (Board of Pharmacy)Status: Pending - no final order shown (2026-10-01)

    Florida MQA lists a public complaint on Strive Pharmacy Tampa, LLC license PH34238 (Special Sterile Compounding), case 202610840, action taken 'AC FILED' (administrative complaint filed). Filing date and allegations not shown on the lookup.

    Primary record

Search log

• FDA warning letters and the FDA compounding inspections, recalls and other actions page — searched October 1, 2026
• openFDA drug enforcement (recall) database — searched October 1, 2026
• FDA Form 483 postings for compounders — searched October 1, 2026
• State Board of Pharmacy license and disciplinary records for the pharmacy's licensed states — searched October 1, 2026

Strive Pharmacy shipping

Turnaround averages 1–5 days depending on the pharmacy; more precise per-pharmacy shipping numbers are coming soon to this profile.

Below are the shipping terms Strive Pharmacy publishes itself. AffinityRx shipping fees are added on top of the medication price: Ground $15, 2-day $15, Overnight $20, and a cold-chain add-on of $8. There is no subscription and there are no per-order fees. See how AffinityRx handles slow pharmacy shipping.

Shipping source

Sources

Every fact on this page comes from the records below or from the AffinityRx catalog. Pharmacy statements are labeled as claimed until verified.

1. https://www.strivepharmacy.com/
2. https://www.strivepharmacy.com/contact
3. https://www.strivepharmacy.com/locations
4. https://www.strivepharmacy.com/higher-standards
5. https://www.strivepharmacy.com/become-a-partner/telehealth-partners
6. https://www.strivepharmacy.com/shipping-policy
7. https://www.strivepharmacy.com/medications/ketamine
8. https://npiregistry.cms.hhs.gov/api/?version=2.1&organization_name=Strive%20Pharmacy*
9. https://www.pharmacy.texas.gov/dbsearch/phy_zoom.asp?id=35643
10. https://www.pharmacy.texas.gov/dbsearch/phy_zoom.asp?id=34585
11. https://www.pharmacy.texas.gov/dbsearch/phy_zoom.asp?id=35538
12. https://www.pharmacy.texas.gov/abo/Detail/3391448%20%20P35643%20%20Strive%20Pharmacy%20LLC%20%20ABO%20%232025-02040%20%202026-02.pdf
13. https://www.pharmacy.texas.gov/abo/Detail/3276895%20%20P34585%20%20Strive%20Pharmacy%20Texas%20LLC%20%20ABO%20%20%232025-01349%20%202026-08.pdf
14. https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders
15. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/strive-pharmacy-texas-llc-dba-strive-pharmacy-639220-05132026
16. https://www.fda.gov/media/172930/download
17. https://sherwood.news/business/exclusive-before-hims-glp-1-pill-fallout-its-pharmacy-partner-was-already/
18. https://www.cnbc.com/2025/04/01/eli-lilly-sues-strive-and-empower-over-compounded-tirzepatide.html
19. https://www.ded.uscourts.gov/sites/ded/files/opinions/25-401.pdf
20. https://www.hmpgloballearningnetwork.com/site/pln/news/compounding-pharmacy-sues-eli-lilly-novo-nordisk-over-alleged-glp-1-antitrust
21. https://birdeye.com/strive-compounding-pharmacy-170377582486157
22. https://striverx.com/
23. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
24. https://www.fda.gov/drugs/human-drug-compounding/compounding-inspections-recalls-and-other-actions
25. https://api.fda.gov/drug/enforcement.json
26. https://www.legitscript.com/websites/
27. https://www.strivepharmacy.com
28. https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthcareProviders/LicenseVerification?LicInd=28806&Procde=2205&org=STRIVE%20PHARMACY%20TAMPA%2C%20LLC&dba=STRIVE%20PHARMACY
29. https://api.fda.gov/drug/enforcement.json?search=event_id:88862&limit=100
30. https://www.fda.gov/media/155943/download
31. https://www.fda.gov/media/155059/download
32. https://www.fda.gov/media/143563/download?attachment
33. https://www.fda.gov/media/135920/download
34. https://api.fda.gov/drug/enforcement.json?search=event_id:74745&limit=100

By Tim Yoon, CEO, AffinityRx · Last updated Oct 2, 2026

Frequently asked questions about Strive Pharmacy